Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.6.2 appears in the record history, and the older v3.6.0 entry is removed. This documents a backend/platform update rather than changes to study data or on-page text.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe latest record version indicates recruitment has ended, and the revision metadata shows a new version (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

- Check27 days agoChange DetectedA new Revision: v3.5.5 is added and the previous Revision: v3.5.4 is removed from the history, updating the page’s revision tag. This administrative metadata change does not affect study content, results, or user-facing functionality.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a newer site build.SummaryDifference0.0%

- Check62 days agoChange DetectedNew latest revision v3.5.3 is added to the history, replacing the previous v3.5.2. This reflects a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision v3.5.2 was added and v3.5.0 was removed in the page's history.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.